Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura

NCT01554514 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Thrombotic Thrombocytopenic Purpura

Interventions

BIOLOGICAL: rituximab

Sponsor

Washington University School of Medicine

Collaborators

[object Object]